Curative Onyx embolization of tentorial dural arteriovenous fistulas

Neurosurg Focus. 2012 May;32(5):E4. doi: 10.3171/2011.12.FOCUS11323.

Abstract

Object: The authors conducted a study to review their experience with tentorial dural arteriovenous fistulas (DAVFs) treated with transarterial endovascular embolization in which Onyx was used.

Methods: The authors reviewed prospectively collected data in 9 patients with tentorial DAVFs treated with Onyx embolization between 2008 and 2011. Information reviewed included clinical presentation, angiographic features, treatment, and clinical and radiologically documented outcome. Clinical follow-up was available in every patient. Radiological follow-up studies were available in 8 of 9 patients (mean follow-up 4.6 months).

Results: Six of 9 patients had complete angiographic obliteration (in 5 this was confirmed by a follow-up angiogram obtained 3-6 months later), and 2 patients had near-complete obliteration (faint filling of the venous drainage in the late venous phase). One patient had partial obliteration and required surgical disconnection. In all patients with complete obliteration, transarterial embolization was performed through the posterior branch of the middle meningeal artery. There were no procedural complications, and no morbidity or mortality resulted from Onyx embolization.

Conclusions: Transarterial Onyx embolization is a valid, effective, and safe alternative to surgical disconnection in many patients with tentorial DAVFs. The presence of an adequate posterior branch of the middle meningeal artery is critical to achieve a microcatheter position distal enough to increase the likelihood of complete obliteration.

MeSH terms

  • Adult
  • Aged
  • Central Nervous System Vascular Malformations / therapy*
  • Cerebral Angiography
  • Cerebral Arteries / surgery
  • Dimethyl Sulfoxide / therapeutic use*
  • Embolization, Therapeutic / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Angiography
  • Male
  • Middle Aged
  • Polyvinyls / therapeutic use*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Onyx copolymer
  • Polyvinyls
  • Dimethyl Sulfoxide